Canada Pension Plan Investment Board Purchases New Shares in Ventas, Inc. $VTR

Key Points

• Canada Pension Plan Investment Board bought 4.37 million Ventas shares worth approximately $387.7 million, giving it a 0.85% stake. Institutional investors and hedge funds collectively own 94.18% of the healthcare REIT.
• Analysts remain broadly positive, with 14 Buy ratings and three Holds producing a “Moderate Buy” consensus and an average price target of $98.00.
• Ventas reported quarterly adjusted earnings of $0.97 per share, exceeding estimates, while revenue rose 21.7% year over year to $1.73 billion. Shares opened at $93.84, near the analyst target.

Canada Pension Plan Investment Board bought a new position in Ventas, Inc. (NYSE:VTR - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 4,366,528 shares of the real estate investment trust's stock, valued at approximately $387,748,000. Canada Pension Plan Investment Board owned about 0.85% of Ventas at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the stock. BlackRock Inc. bought a new position in Ventas in the 2nd quarter valued at $4,953,439,000. Capital World Investors bought a new stake in shares of Ventas during the fourth quarter worth $594,116,000. Norges Bank bought a new stake in shares of Ventas during the fourth quarter worth $474,571,000. Legal & General Group Plc bought a new stake in shares of Ventas during the second quarter worth $501,850,000. Finally, Deutsche Bank AG acquired a new position in shares of Ventas during the second quarter valued at $451,822,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

VTR has been the topic of several recent research reports. Royal Bank Of Canada raised their price target on Ventas from $98.00 to $99.00 and gave the company an "outperform" rating in a report on Friday, August 14th. Cantor Fitzgerald boosted their price objective on Ventas from $97.00 to $102.00 and gave the stock an "overweight" rating in a report on Friday, July 31st. KeyCorp upped their target price on shares of Ventas from $90.00 to $95.00 and gave the company an "overweight" rating in a research report on Thursday, May 7th. UBS Group raised their target price on shares of Ventas from $85.00 to $93.00 and gave the company a "neutral" rating in a research note on Monday, May 4th. Finally, Barclays initiated coverage on shares of Ventas in a research report on Tuesday, July 7th. They set an "equal weight" rating and a $99.00 price target for the company. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $98.00.

Ventas Stock Up 0.4%

Shares of NYSE VTR opened at $93.84 on Wednesday. Ventas, Inc. has a 52-week low of $66.38 and a 52-week high of $101.60. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The stock has a market cap of $48.14 billion, a P/E ratio of 173.79, a P/E/G ratio of 2.16 and a beta of 0.69. The firm has a 50 day moving average price of $91.76 and a 200 day moving average price of $87.38.

Ventas (NYSE:VTR - Get Free Report) last posted its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.01. The company had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business's revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period last year, the business posted $0.87 earnings per share. Analysts expect that Ventas, Inc. will post 3.89 EPS for the current year.

Insider Activity at Ventas

In other Ventas news, Director Michael J. Embler acquired 2,500 shares of the company's stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares of the company's stock, valued at $1,513,309.62. This represents a 14.97% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.53% of the stock is currently owned by corporate insiders.

About Ventas

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source